a prospective study of a-interferon and autologus bone marrow transplantation in chronic myeloid leukemia

Meloni, G.
Russo, D.
Baccarani, M.
Testoni, N.
Martinelli, G.
Fanin, R.
Zuffa, E.
Giannantonio, R.
Alimena, Giuliana
Saglio, G.
Mandelli, Franco
Tura, S.

Publication date

January 1999

Publisher

Fondaz Ferrata Storti:Strada Nuova 134, 27100 Pavia Italy:011 39 0382 531182, EMAIL: office@haematologica.it, Fax: 011 39 0382 27721

Abstract

BACKGROUND AND OBJECTIVE: Alpha-interferon (alphaIFN) can induce cytogenetic remissions in chronic myeloid leukemia (CML). Hemopoietic progenitors can be collected from the marrow in remission and utilized for autologous repopulation after high dose chemotherapy. This study was designed with the purpose of evaluating the feasibility of a combined treatment policy of alphaIFN followed by autologous bone marrow transplantation (autoBMT)

Extracted data

We use cookies to provide a better user experience.

Data Protection

a prospective study of a-interferon and autologus bone marrow transplantation in chronic myeloid leukemia

Abstract

Extracted data

a prospective study of a-interferon and autologus bone marrow transplantation in chronic myeloid leukemia

Abstract

Extracted data

Related items

Related items